(R)-tert-Butyl 3-((2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate

Catalog No. :
ACJOHU953
CAS No. :
1314356-30-3
Molecular Formula :
C14H21N3O3S
Molecular Weight :
311.41

IUPAC Name:tert-butyl (R)-3-((2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate

(R)-tert-Butyl 3-((2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$593.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 3-((2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl (R)-3-((2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate
Molecular FormulaC14H21N3O3S
Molecular Weight311.41
SMILESO=C(N1C[C@H](OC2=NC(SC)=NC=C2)CC1)OC(C)(C)C
InChI KeyXIIOZLKDSAREGL-SNVBAGLBSA-N
Synonym(R)-3-(2-Methylsulfanyl-pyrimidin-4-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester
CAS No.1314356-30-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJOHU953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIGP018 route compound structure diagram
    ACEIGP018109431-87-0 In Stock
  2. Plus
  3. ACJTIO123 route compound structure diagram
    ACJTIO12349844-90-8 In Stock
  4. Then
  5. ACJOHU953 route product structure diagram
    ACJOHU9531314356-30-3
Inquiry

2. ACJOHU953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIGP018 route compound structure diagram
    ACEIGP018109431-87-0 In Stock
  2. Plus
  3. ACRQIP405 route compound structure diagram
    ACRQIP405959236-97-6 In Stock
  4. Then
  5. ACJOHU953 route product structure diagram
    ACJOHU9531314356-30-3
Inquiry

Comments (0)